Please login to the form below

Not currently logged in
Email:
Password:

Bayer restructures its operations, drops Bayer Healthcare group

Will instead have divisions for pharmaceuticals, consumer health and crop science
Bayer

Bayer is reorganising its company with the firm to be realigned into three distinct divisions from January next year.

The announcement comes shortly after Bayer completed the divestment of its polymer materials business, Bayer MaterialScience, which now operates under the name Covestro.

The company's board of management of Bayer AG has proposed the company be managed by three separate, but integrated divisions: pharmaceuticals, consumer health and crop science.

As part of the reorganisation, the Bayer HealthCare subgroup will be dissolved as each division will focus on core competencies close to their businesses – R&D, production, and sales & marketing.

Werner Wenning, chairman of the supervisory board of Bayer AG, said: “In recent years, Bayer has continued developing its portfolio with a significant focus on Life Sciences. The company's very strong position at this time enables it to concentrate exclusively on these businesses.

“We are convinced that the greater integration of strategic and operational roles will take Bayer forward and we have expanded the roles of Board of Management accordingly.”

The board will add four new executives, with effect from January 1, 2016, increasing its size to eight members.

Dieter Weinand will join the board from the pharmaceuticals division and Erica Mann has been appointed from the consumer care division.

Additionally, Liam Condon and Dr Hartmut Klusik will also join the board of managers. Condon has been chairman of the executive committee of Bayer cropscience since 2012 and Klusik has been on the HealthCare Executive Committee since 2005.

Despite the reorganisation of the company, job numbers are expected to remain stable in the coming years, both in Germany and the rest of the world.

The future product portfolio of the pharmaceuticals division is intended to bring together prescription medicines from the general medicine, specialty categories and the radiology business.

The consumer health division will encompass globally known consumer brands across many areas including allergies, cardiovascular risks and dermatology.

The crop science division, Bayer's agriculture business is active in the seed, chemical and biological crop protection and non-agricultural pest control markets.

Dr Marijn Dekkers, chairman of the board, said: “The aim of the new organisation is to provide the best-possible support to Bayer's strategy as a leading Life Science company and to put ourselves in an even stronger position vis-à-vis our competitors.”  

Article by
Nikhil Patel

30th September 2015

From: Sales, Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics